Geralyn Lambert-Messerlian, PhD, FACB, of Greenville, associate director of the Division of Medical Screening and Special Testing at Women & Infants Hospital of Rhode Island has been promoted to professor of Pathology and Laboratory Medicine at The Warren Alpert Medical School of Brown University, where she has been an associate professor since 2005.Dr. Messerlian is also the associate director of the Center for Biomarkers and Emerging Technologies in the Department of Obstetrics and Gynecology at Women & Infants.
Dr. Messerlian's work with the reproductive hormone inhibin proved instrumental in the development of clinical applications of the inhibin immunoassay in prenatal screening for Down syndrome – a test now used throughout the world – as well as in the assessment of ovarian reserve.She has multiple ongoing research projects in collaboration with the investigators in the departments of Obstetrics and Gynecology and Pathology and Laboratory Medicine at Women & Infants and recently managed a trial funded by the National Institutes of Health, the results of which were published in the New England Journal of Medicine.
A graduate of Wheaton College, Dr. Messerlian earned her PhD in Reproductive Endocrinology at Boston University.She is a fellow of the National Academy of Clinical Biochemistry (FACB).Dr. Messerlian is a member of the Endocrine Society and the American Association of Clinical Chemists.
About Women & Infants Hospital
Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation's leading specialty hospitals for women and newborns.A U.S.News Best Hospital in Gynecology and Best Children's Hospital in Neonatology, Women & Infants was ranked number one in the Providence metro area and a top-performer in cancer, and has achieved a 5-star rating in Maternity Care for 2011 from HealthGrades.The primary teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women's medicine, Women & Infants is the seventh largest obstetrical service in the country with more than 8,500 deliveries per year.In 2009, Women & Infants opened the country's largest, single-family room neonatal intensive care unit.
New England's premier hospital for women and newborns, Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility.It is home to the nation's only mother-baby perinatal psychiatric partial hospital, as well as the nation's only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Center of Excellence from the American College of Radiography; a Center for In Vitro Maturation Excellence by SAGE In Vitro Fertilization; a Center of Biomedical Research Excellence by the National Institutes of Health; and a Neonatal Resource Services Center of Excellence.It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute's Gynecologic Oncology Group.